The Patient-Centered Outcomes Research Institute® (PCORI) has approved the RAPTOR-CIED Study to advance from its feasibility phase to the full study phase, following the successful completion of early project milestones.
The study is led by Daniel Kramer, MD, Section Head of Electrophysiology and Digital Health, and Issa Dahabreh, MD, MS, ScD, Associate Professor of Epidemiology and Biostatistics at the Harvard T.H. Chan School of Public Health and Section Head of Epidemiology and Data Science at the Smith Center for Outcomes Research, in collaboration with the Electrophysiology & Digital Health team at Beth Israel Deaconess Medical Center (BIDMC) and research partners across the country.
This award builds on the successful feasibility phase of The Remote Alert Pathway to Optimize CaRe of Cardiac Implantable Electrical Devices (RAPTOR‑CIED) Study , which received PCORI funding in July 2024. During the feasibility phase, the team demonstrated the viability and patient-centered value of a novel, digitally enabled pathway for managing remote alerts from cardiac implantable electronic devices.
“Very grateful for my lead statistician Issa Dahabreh and our co-investigators at BIDMC and enrolling centers for making our feasibility phase successful. Looking forward to the next challenge!” said Kramer.
The full study phase will build on this work evaluating remote alert care pathway at scale, with the goal of generating actionable evidence to improve clinical outcomes, enhance patient experience, and support more efficient delivery of electrophysiology care.
About the Smith Center for Outcomes Research
Founded in 2015, The Smith Center for Outcomes Research at Beth Israel Deaconess Medical Center conducts rigorous, patient-centered research to improve health outcomes and inform clinical decision-making. Embedded within a Harvard Medical School teaching affiliate, the Center combines novel analytical approaches with deep clinical expertise to understand and improve patient outcomes and advance healthcare delivery. Their work has influenced national policy, generated new clinical insights, and increased access to high-quality, affordable care. To get news as soon as it happens, follow us on X/Twitter and LinkedIn.